This inventor holds 26 USPTO granted patents and 27 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in Antiviral Nucleosides. Top assignees: Emory University, Chimerix, Inc., Gilead Sciences, Inc.. Active years: 1993-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Chapel Hill, NC (US) (1993 - 2015)
- Atlanta, GA (US) (2018 - 2024)
Company Filing History:
15 out of 1,024 
5 out of 28 
2 out of 946 
Years Active: 1993-2026
Areas of Expertise:
Title: **George R. Painter: Innovator in Pharmaceutical Science**
Introduction
George R. Painter is a renowned inventor based in Chapel Hill, North Carolina, with an impressive portfolio of 23 patents. His contributions to pharmaceutical science, particularly in the field of antiviral treatments, have positioned him as a significant figure in addressing viral infections.
Latest Patents
Among his latest patents, George R. Painter has been involved in groundbreaking work on N4-hydroxycytidine and its derivatives. This disclosure encompasses certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods for treating or preventing viral infections, including Eastern, Western, and Venezuelan Equine Encephalitis (EEE, WEE, and VEE), Chikungunya fever, Ebola, Influenza, RSV, and Zika virus infection using these innovative compounds. Additionally, he has developed pharmaceutical compositions containing substituted nucleotides and nucleosides that aim to treat viral infections, further expanding the therapeutic options available in the market.
Career Highlights
George has built a distinguished career, having worked with prominent institutions such as Emory University and Chimerix, Inc. His academic and practical experiences have greatly contributed to the advancement of antiviral therapies, promoting public health and safety.
Collaborations
Throughout his career, George R. Painter has collaborated with notable colleagues, including Merrick R. Almond and Gregory R. Bluemling. These partnerships have enriched his research and facilitated the development of innovative solutions to combat viral diseases.
Conclusion
George R. Painter's extensive patent portfolio reflects his dedication to innovation in pharmaceutical science. By developing antiviral treatments that address significant health challenges, his work continues to impact the field positively, demonstrating the crucial role of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile